These success, along with a preceding report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two aid the principle of focusing on ACKR3 as a singular solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-sim